In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.


The free consultation period for this content is over.

It is now only available year-round to ACNAP Silver Members, Fellows of the ESC and Young combined Members

"Low physical activity in patients with heart failure and lack of motivation or general health issues as exercise barriers"

Session Poster Session 2

Speaker Rafael Mesa Rico

Congress : EuroHeartCare 2019

  • Topic : heart failure
  • Sub-topic : Chronic Heart Failure - Treatment
  • Session type : Poster Session
  • FP Number : P249

Authors : E Marques-Sule (Valencia,ES), M Romero Fuentes (Valencia,ES), S Senra (Basingstoke,GB), L Almenar (Valencia,ES), R Lopez Vilella (Valencia,ES), S Perez-Alenda (Valencia,ES), R Mesa Rico (Marbella,ES), E Timonet Andreu (Marbella,ES), C Braza Dominguez (Marbella,ES), JC Canca Sanchez (Marbella,ES), AL Fernandez-Oliver (Malaga,ES), R Mgueraman-Jilali (Malaga,ES), MC Gutierrez Del Pino (Malaga,ES), F Querol-Fuentes (Valencia,ES)

Authors:
E Marques-Sule1 , M Romero Fuentes1 , S Senra2 , L Almenar3 , R Lopez Vilella3 , S Perez-Alenda1 , R Mesa Rico4 , E Timonet Andreu4 , C Braza Dominguez4 , JC Canca Sanchez4 , AL Fernandez-Oliver5 , R Mgueraman-Jilali5 , MC Gutierrez Del Pino5 , F Querol-Fuentes1 , 1University of Valencia, Physio-therapy - Valencia - Spain , 2Basingstoke and North Hamphire Hospital, Research and Development - Basingstoke - United Kingdom of Great Britain & Northern Ireland , 3University Hospital La Fe, Heart failure and heart transplant unit - Valencia - Spain , 4Hospital Costa del Sol - Marbella - Spain , 5University Hospital Virgen de la Victoria - Malaga - Spain ,

Citation:

Background: Patients with Heart Failure (HF), usually present with very low levels of physical activity. However, there is little scientific evidence about the reasons that prevent the practice of regular exercise.

Purpose: The aim of our work was to determine the level of physical activity (PA) in patients with a diagnostic of heart failure and the barriers that prevent them from carry out more exercise.

Method: A cross-sectional study was performed in patients with HF (n=110). The study was approved by the Regional Ethics Committee.

The levels of PA were measured with the use of an international physical activity questionnaire (IPAQ). The barriers to perform the exercise were evaluated via a brief structured interview. Prior to the interview, the participants were encouraged to identify the reasons that frequently prevented them to practice physical exercise and enough time was allowed to consider this. The process followed by a discussion with each individual to try and establish the nature and number of barriers encountered.

Results: From the 82 HF participants, it was found that neither of them performed the high-level PA (3000MET). 11% performed moderate PA (600-3000MET) and 89% of participants confirmed that they performed low level PA (<600). The total METS measure for the total of participants was 769,64. The participants stated to practice a small part of vigorous exercise such as swimming, aerobics or cycling. Moderated activities such as carrying loads, or cycling at a steady pace or jogging. It was determined that generally, participants were sedentary/resting for an average of 820,24 minutes.

The most frequent barriers were the ‘lack of motivation’ (95,1%). Closely followed by ‘other health problems’ (84.1%),‘climate conditions (65.9%). While less frequent barriers were lack of time to exercise due to work commitments (19,5%) and lack of time in general(20,7%).

Conclusion: the level of physical activity in patients with HF is generally low, with a great tendency to sedentary life styles. The main barriers identified were lack of motivation, generic health issues and the feeling that they are not fit to perform physical activities.



Based on your interests

Three reasons why you should become a member

Become a member now
  • 1Access your congress resources all year-round on the New ESC 365
  • 2Get a discount on your next congress registration
  • 3Continue your professional development with free access to educational tools
Become a member now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are